Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benet (sodium risedronate) 48-week all-case surveillance in osseous Paget's disease
jRCT1080222430
- Sponsor
- Takeda
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of risedronate in Paget's disease of bone, sponsored by Takeda.
02
Drugs
risedronate
03
Conditions
Paget's disease of bone
Beyond the preview
Go deeper on jRCT1080222430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222430.